{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-23-005859","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2023-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.430214+00:00","generated_at":"2026-06-09T17:23:26.827911+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cadrenal Therapeutics stockholders elect directors and ratify auditor at 2023 annual meeting","bullets":["Quang Pham re-elected as Class I director with 10,183,242 votes for, 8,560 withheld; Glynn Wilson with 10,139,612 for, 52,190 withheld.","WithumSmith+Brown, P.C. ratified as independent auditor for fiscal 2023 with 11,126,433 for, 10,899 against, 192 abstain.","Quorum achieved with over 34% of 13,022,754 outstanding shares represented at the October 20, 2023 meeting.","Broker non-votes totaled 945,722 for each director election; none for the auditor ratification (routine matter)."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-23-005859","json":"https://secwatch.observer/filing/0001013762-23-005859.json","markdown":"https://secwatch.observer/filing/0001013762-23-005859.md","text":"https://secwatch.observer/filing/0001013762-23-005859.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000101376223005859/0001013762-23-005859-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000101376223005859/ea187126-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T17:23:26.827911+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"888206b2d1d56f49440cd2c156a2c06e0fa42495","claim":"Cadrenal Therapeutics, Inc. shareholders approved Ratification of the appointment of WithumSmith+Brown, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-10-20 meeting.","evidence_excerpt":"Proposal 2 . Ratification of the appointment of WithumSmith+Brown, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2023 . The stockholders ratified and approved the appointment of WithumSmith+Brown, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2023 based on the votes listed below: Votes For Votes Against Abstentions Broker Non-Votes 11,126,433 10,899 192 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1937993/000101376223005859/0001013762-23-005859-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-10-20"}],"fact_type":"shareholder_vote"},{"claim_id":"f2664d89ffdfe5f5c04d5cb7ecfc064ee812e170","claim":"Cadrenal Therapeutics, Inc. shareholders approved Election of Directors at the 2023-10-20 meeting.","evidence_excerpt":"Proposal 1 . Election of Directors . The following two (2) individuals were elected as Class I directors, to serve until the Company’s 2026 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified with the following votes: Name of Director Votes For Withheld Broker Non-Votes Quang Pham 10,183,242 8,560 945,722 Glynn Wilson 10,139,612 52,190 945,722","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1937993/000101376223005859/0001013762-23-005859-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-10-20"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}